4.7 Article

Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Journal

CANCER DISCOVERY
Volume 12, Issue 1, Pages 134-153

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-21-0316

Keywords

-

Categories

Funding

  1. National Natural Science Foundation of China [81961128025, 91942313]
  2. Program of Shanghai Academic Research Leader [19XD1420700]
  3. Shanghai Municipal Key Clinical Specialty
  4. Strategic Priority Research Program [XDPB0303]
  5. Frontier Science Key Research Project of Chinese Academy of Sciences [QYZDB-SSW-SMC036]
  6. Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]

Ask authors/readers for more resources

This study presents a single-cell and spatial atlas of colorectal liver metastasis, revealing highly metabolically activated MRCP+ CCL18(+) M2-like macrophages at the metastatic sites. Effective neoadjuvant chemotherapy can slow down this metabolic activation, raising the possibility of targeting metabolic pathways in metastasis.
Liver metastasis, the leading cause of colorectal cancer mortality, exhibits a highly heterogeneous and suppressive immune microenvironment. Here, we sequenced 97 matched samples by using single-cell RNA sequencing and spatial transcriptomics. Strikingly, the metastatic microenvironment underwent remarkable spatial reprogramming of immunosuppressive cells such as MRCP+ CCL18(+) M2-like macrophages. We further developed scMetabolism, a computational pipeline for quantifying single-cell metabolism, and observed that those macrophages harbored enhanced metabolic activity. Interestingly, neoadjuvant chemotherapy could block this status and restore the antitumor immune balance in responsive patients, whereas the nonresponsive patients deteriorated into a more suppressive one. Our work described the immune evolution of metastasis and uncovered the black box of how tumors respond to neoadjuvant chemotherapy. SIGNIFICANCE: We present a single-cell and spatial atlas of colorectal liver metastasis and found the highly metabolically activated MRCP+ CCL18(+) M2-like macrophages in metastatic sites. Efficient neoadjuvant chemotherapy can slow down such metabolic activation, raising the possibility to target metabolism pathways in metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available